article thumbnail

GSA guides providers, older patients to vaccine consensus

Scienmag

In “Vaccines for Older Adults: Overcoming the Challenges of Shared Clinical Decision Making,” a new white paper from The Gerontological Society of America (GSA) National Adult Vaccination Program, a team of experts outlines a set of recommendations to encourage better definition and increased understanding of how health professionals talk (..)

article thumbnail

Study shows breakthrough COVID was rare among vaccinated seniors

Medical Xpress

A new study published in the Journal of American Medical Directors (JAMDA) found that the risk of severe COVID-19 illness among nursing home residents with complete vaccination are low.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Elderly with few antibodies may need an extra dose of COVID-19 vaccine: Study

Medical Xpress

The new mRNA vaccines have just as good a protective effect against COVID-19 for the very oldest as for younger people. However, the study shows that elderly people with a low antibody response after vaccination were at increased risk of dying from the omicron variants of the disease.

article thumbnail

Increasing staff vaccination at nursing homes cuts COVID-19 infections

Medical Xpress

Before the omicron wave, increasing vaccination for staff at U.S. nursing homes was associated with fewer COVID-19 cases and deaths among residents and fewer cases among staff, according to a study published online Dec. 29 in JAMA Network Open.

Nurses 99
article thumbnail

Parsing chronological and biological age effects on vaccine responses

Medical Xpress

A new editorial paper was published in Aging, titled, "Parsing chronological and biological age effects on vaccine responses."

article thumbnail

PCORI approves $11 million for studies to boost COVID-19 vaccination among long-term care workers

Scienmag

Results could help boost immunization rates during and beyond pandemic among key health care workers WASHINGTON, DC — Two new studies comparing ways to boost COVID-19 vaccination rates that were approved for nearly $11 million in new funding today by the Patient-Centered Outcomes Research Institute (PCORI) aim to reduce high rates of vaccine (..)

article thumbnail

Ad26.RSV.preF-RSV preF protein vaccine immunogenic in seniors

Medical Xpress

An adenovirus serotype 26 respiratory syncytial virus (RSV) vector encoding a prefusion F (preF) protein (Ad26.RSV.preF) RSV.preF) in combination with RSV preF protein is immunogenic and prevents RSV-mediated lower respiratory tract disease in older adults, according to a study published in the Feb.

Protein 96